Delivery Order SPE2DB24D1104-SPE2DB25FYDQ0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes. This competitive, firm fixed-price delivery order, issued on July 22, 2025, is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition to this established...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $18,245.00 and a performance period ending on May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a $3,649 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corporation by the Defense Logistics Agency (DLA) for the provision of GEL-ONE 30 MG/3 ML syringes. The order has an ultimate completion date of December 24, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract has a firm fixed-price pricing type and a ceiling value of $36,490.00. The period of performance extends until May 29, 2025. This delivery order is placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract has a ceiling value of $7,298.00 and runs through January 3, 2025. The contract was awarded on December 11, 2024 and uses a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,473.50, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 21, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of global pharmaceutical distributor Amerisourcebergen Corporation. The $21,163.20 delivery order is for GEL-ONE 30 MG/3 ML SYRINGE 3ML, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,596.00, is a Firm Fixed Price Delivery Order for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 10, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,947.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The contract has an ultimate completion date of April 14, 2025 and is a firm-fixed price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML. The contract has a firm fixed price of $10,947.00 and a period of performance ending on June 6, 2025. This award is not set-aside and represents an individual delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00....
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYDQ0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $3,649.00 and an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The parent IDC functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA awards delivery orders against this contract vehicle to meet immediate medical supply requirements for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/23/25 |